Dr. Kutzkey was formerly a scientist at KAI Pharmaceuticals. At KAI Tim’s research focused on cell assay and pharmacodynamic marker development for selective protein kinase C inhibitors. Prior to KAI, Tim worked at UC Berkeley as a graduate student and postdoctoral scholar in the lab of Dr. Robert Tjian. He completed his Ph.D. in 2005 on the biochemistry and genetics of long range gene regulatory mechanisms. Tim was previously educated at Stanford University.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Cajal Neuroscience | Board Member | Nov 29, 2022 | — | Detail |